| Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch - Flutiform 125/5, Druckgasinhalation, Suspension | | 63032 | | 02 | | Flutiform 125/5 | | Druckgasinhalation, Suspension | | R03AK11 | | Formoterol and Fluticasone | | 20.01.2014 | | |
| | Composition | | fluticasoni propionas 125 µg pro dosi, formoteroli fumaras dihydricus 5 µg pro dosi, natrii cromoglicas, ethanolum 1 mg, apafluranum ad aerosolum, doses pro vase 120. | | Packungsbestandteile | | Druckgasinhalation | | | | | | | | Principe actif | Concentr. |
|---|
| Fluticasoni Propionas | 125 µg | | Formoteroli Fumaras Dihydricus | 5 µg |
| | BAG: Principe actif | Concentr. |
|---|
| Fluticasoni-17 Propionas | 125 mcg | | Formoteroli Fumaras Dihydricus | 5 mcg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Apafluranum ad Aerosolum | | | Ethanol | 1 mg | | Sodium Cromoglicate | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 120 | 41.27 | 61.30 | B | LS | Oui |
|
|
